*Some Market data delayed by 15 mins.

Silexion Therapeutics Corp Ordinary Shares

Symbol: SLXN (NASDAQ)
3.33 ▼ (-1.77%) -0.060

Company Description:
Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals into the cell. Its product candidate, SIL204, consists of locally administered small interfering RNAs, or siRNA, in a solution, as a first-line treatment of locally advanced pancreatic cancer patients, or LAPC, in combination with standard-of-care chemotherapy. It is currently focused on treatment for pancreatic cancer tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected and are non-resectable, i.e. it is not able to be surgically removed.

Key Stats
  • Today's Open: $3.71
  • Today's High: $4.914
  • Today's Low: $3.255
  • Today's Volume: 5.62M
  • Yesterday Close: $3.39
  • Yesterday High: $3.57
  • Yesterday Low: $3.34
  • Yesterday Volume: 198.49K
  • Last Min Volume: 5
  • Last Min High: $3.33
  • Last Min Low: $3.33
  • Last Min VWAP: $3.33
Company Profile
  • Name: Silexion Therapeutics Corp Ordinary Shares
  • Website: https://silexion.com
  • Listed Date: 2024-08-16
  • Location: RAMAT GAN, L3
  • Market Status: Active
  • CIK Number: 0002022416
  • SIC Code: 2836
  • SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Market Cap: $10.60M
  • Round Lot: 100
  • Outstanding Shares: 3.13M
  • Asset Type: CS
RECENT FILINGS FOR SLXN
Filing Date Filing Type Format
2025-09-30 8-K View
2025-09-26 S-3 View
2025-09-26 8-K View
2025-09-25 8-K View
2025-09-23 SCHEDULE 13D/A View
2025-09-18 SCHEDULE 13G View
2025-09-17 SCHEDULE 13G View
2025-09-15 SCHEDULE 13G/A View
2025-09-15 SCHEDULE 13G View
2025-09-15 8-K View
2025-09-15 SCHEDULE 13G View
2025-09-12 8-K View
2025-09-12 424B4 View
2025-09-11 EFFECT View
2025-09-11 8-K View
2025-09-05 S-1 View
2025-09-04 EFFECT View
2025-09-04 8-K View
2025-09-04 424B3 View
2025-09-02 8-K View
Latest News on SLXN

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.